Une tumeur du vagin à ne pas méconnaitre, l’adénocarcinome mésonephrique: à propos d’un cas et revue de la literature

L'adénocarcinome mésonéphrique du vagin est une tumeur maligne extrêmement rare avec uniquement trois cas publiés dans la littérature jusqu'à maintenant. Il dérive des reliquats embryonnaires des canaux mésonéphriques au niveau du vagin. Nous rapportons un cas d'adénocarcinome mésonéphrique du vagin survenant chez une femme de 50 ans, et révélé par une masse polyploïde du vagin. L'IRM a montré un envahissement du périnée et de la branche inférieure du pubis. L'étude anatomo-pathologique était en faveur d'un adénocarcinome mésonéphrique dont les cellules tumorales expriment la pancytokératine et le CD10. Elles ne sont pas marquées par les anticorps anti récepteurs ostrogéniques et progestatifs. La patiente a été adressée pour radiothérapie avant la prise en charge chirurgicale. Les auteurs soulignent à travers cette observation les aspects étiopathogéniques, histologiques et thérapeutiques de cette tumeur rare

Comparison of a fluorometric assay kit with high-performance liquid chromatography for the assessment of serum retinol concentration.

Background: Although high-performance liquid chromatography (HPLC) is the commonly used method for the analysis of retinol in biological samples, simple and rapid test kits are available.Objectives: This study compared a rapid test kit (ICHECK Fluoro®) to HPLC for the assessment of serum retinol concentrations.Methods: For the analysis by HPLC, sample preparation included standard deproteinization and extraction phases. The analysis by ICHECK was performed by injecting serum into IEX reagent vials (n=89) and mixing manually for separation. After precipitation of the proteins, the vial was introduced into the chamber of the ICHECK Fluoro and analysed at 0 min (ICHECK0min) and 15 min later (ICHECK15min). Bland and Altman approach was applied to test the agreement between HPLC and ICHECK.Results: Mean HPLC, ICHECK0min and ICHECK15min values were 421.2±106.0 μg/L, 423.1±118.3 μg/L and 413.2±107.6 μg/L, respectively. Retinol concentrations significantly decreased in the IEX solution over time (p<0.001). No significant proportional bias was observed between HPLC and ICHECK0min (r-0.038, p=0.73) and ICHECK15min (r=- 0.024, p=0.82). Fixed biases (HPLC minus ICHECK) for ICHECK0min and ICHECK15min were respectively -1.9±23.1 μg/l (p=0.45) and 8.0±22.7 μg/l (p=0.002).Conclusion: ICHECK Fluoro may offer a reliable mean for assessing serum retinol for measurements performed with no significant time delay.Keywords: HPLC, ICHECK Fluoro, serum retinol, test kit, vitamin A status

T-matrix representation of optical scattering response: Suggestion for a data format

The transition matrix, frequently abbreviated as T-matrix, contains the complete information in a linear approximation of how a spatially localized object scatters an incident field. The T-matrix is used to study the scattering response of an isolated object and describes the optical response of complex photonic materials made from ensembles of individual objects. T-matrices of certain common structures, potentially, have been repeatedly calculated all over the world again and again. This is not necessary and constitutes a major challenge for various reasons. First, the resources spent on their computation represent an unsustainable financial and ecological burden. Second, with the onset of machine learning, data is the gold of our era, and it should be freely available to everybody to address novel scientific challenges. Finally, the possibility of reproducing simulations could tremendously improve if the considered T-matrices could be shared. To address these challenges, we found it important to agree on a common data format for T-matrices and to enable their collection from different sources and distribution. This document aims to develop the specifications for storing T-matrices and associated metadata. The specifications should allow maximum freedom to accommodate as many use cases as possible without introducing any ambiguity in the stored data. The common format will assist in setting up a public database of T-matrices

Guidance on minimum information requirements (MIR) from designing to reporting human biomonitoring (HBM)

Funding Information: We would like to thank all the experts active in the International Society for Exposure Science (ISES) European Regional Chapter, working group on Human biomonitoring (ISES Europe HBM working group) and the HBM Global Network for their support and contributions. Additionally, special thanks to ECETOC for supporting this initiative and development of www.FAIREHR.com platform. Ethical approval was not required for the work reported in this manuscript as this did not involve human subjects, human material, or human data, nor experiments on live vertebrates and/or higher invertebrates. The findings and conclusions in this presentation are those of the authors and do not necessarily represent the official position of their employers or any agency of the U.S. Government. Use of trade names is for identification only and does not imply endorsement by the EPA, CDC, or the US Department of Health and Human Services. The research presented was not performed or funded by EPA and was not subject to EPA's quality system requirements. No financial assistance was received in support of this work. Publisher Copyright: © 2025 The AuthorsHuman biomonitoring (HBM) provides an integrated chemical exposures assessment considering all routes and sources of exposure. The accurate interpretation and comparability of biomarkers of exposure and effect depend on harmonized, quality-assured sampling, processing, and analysis. Currently, the lack of broadly accepted guidance on minimum information required for collecting and reporting HBM data, hinders comparability between studies. Furthermore, it prevents HBM from reaching its full potential as a reliable approach for assessing and managing the risks of human exposure to chemicals. The European Chapter of the International Society of Exposure Science HBM Working Group (ISES Europe HBM working group) has established a global human biomonitoring community network (HBM Global Network) to develop a guidance to define the minimum information to be collected and reported in HBM, called the “Minimum Information Requirements for Human Biomonitoring (MIR-HBM)”. This work builds on previous efforts to harmonize HBM worldwide. The MIR-HBM guidance covers all phases of HBM from the design phase to the effective communication of results. By carefully defining MIR for all phases, researchers and health professionals can make their HBM studies and programs are robust, reproducible, and meaningful. Acceptance and implementation of MIR-HBM Guidelines in both the general population and occupational fields would improve the interpretability and regulatory utility of HBM data. While implementation challenges remain—such as varying local capacities, and ethical and legal differences at the national levels, this initiative represents an important step toward harmonizing HBM practice and supports an ongoing dialogue among policymakers, legal experts, and scientists to effectively address these challenges. Leveraging the data and insights from HBM, policymakers can develop more effective strategies to protect public health and ensure safer working environments.publishersversionpublishe

26th Annual Computational Neuroscience Meeting (CNS*2017): Part 3 - Meeting Abstracts - Antwerp, Belgium. 15–20 July 2017

This work was produced as part of the activities of FAPESP Research,\ud Disseminations and Innovation Center for Neuromathematics (grant\ud 2013/07699-0, S. Paulo Research Foundation). NLK is supported by a\ud FAPESP postdoctoral fellowship (grant 2016/03855-5). ACR is partially\ud supported by a CNPq fellowship (grant 306251/2014-0)